세포 계수 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 최종 사용자별, 지역별 - 산업 예측(2024-2031년)

Global Cell Counting Market size was valued at USD 9.8 billion in 2022 and is poised to grow from USD 10.47 billion in 2023 to USD 17.72 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The cell counting market is witnessing robust growth driven by the increasing focus on research in areas such as cell biology, cancer research, and immunology. This market expansion is primarily fueled by the rising demand for personalized medicine, the surge in chronic disease cases, and ongoing advancements in cell counting technologies. However, challenges such as technical complexities and a shortage of skilled personnel to operate these technologies present hurdles to market growth. Despite these constraints, the outlook remains positive as the industry evolves with the introduction of innovative technologies and the rising significance of cell-based therapies. Additionally, the integration of digital technologies is transforming cell counting methods, further boosting market potential. As a result, the cell counting market is expected to continue its upward trajectory, accommodating a diverse range of applications in medical research and diagnostics, and ultimately enhancing the quality of healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Counting Market Segmental Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Counting Market

The Global Cell Counting market is significantly driven by major advancements in technology, including the development of superior automated cell counters, high-tech flow cytometers, and enhanced imaging systems. These innovations enhance the reliability and efficiency of cell counting processes, thereby increasing demand across various sectors such as clinical diagnostics and research. The improved accuracy and speed of these advanced systems not only facilitate precise cell analysis but also contribute to better clinical outcomes and research efficacy. As healthcare and life sciences continue to emphasize the importance of accurate diagnostics and data-driven research, the demand for advanced cell counting solutions is poised for robust growth.

Restraints in the Global Cell Counting Market

One significant market restraint affecting the Global Cell Counting market is the limited reimbursement options available for certain cell counting systems in various regions. This inadequacy can negatively influence the financial feasibility of adopting advanced technologies, thereby detracting from potential demand. The financial burden on researchers and healthcare providers arising from insufficient reimbursement may deter them from exploring and investing in novel cell counting solutions, ultimately impeding innovation and growth in the sector. As a result, the hesitance to embrace cutting-edge cell counting technologies due to reimbursement issues poses a considerable challenge to market expansion and development.

Market Trends of the Global Cell Counting Market

The Global Cell Counting Market is witnessing a notable trend characterized by a heightened emphasis on assessing cell functionality and viability, moving beyond traditional counting methods. Researchers and clinicians are increasingly recognizing the importance of evaluating cell activity and health, particularly in applications such as drug development, cancer research, and regenerative medicine. This demand is driving innovation in technologies that not only quantify cells but also provide comprehensive insights into cellular behavior. As a result, novel solutions are being developed to enhance the accuracy and efficiency of cell viability assays, thereby expanding the scope of applications and fostering growth within the market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Value Chain Analysis
• Case Study Analysis

Cell Counting Market by Product

• Market Overview
• Consumables
  • Media, Sera, And Reagents
  • Assay Kits
  • Microplates
  • Accessories
  • Other Consumables
• Instruments
  • Spectrophotometers
  • Single-Mode Readers
  • Multi-Mode Readers
  • Flow Cytometers
  • Hematology Analyzers
  • Fully Automated Analyzers
  • Semi-Automated Hematology Analyzers
  • Cell Counters
  • Automated Cell Counters
  • Hemocytometers/Manual Cell Counters
  • Microscopes

Cell Counting Market by Application

• Market Overview
• Research Applications
  • Cancer Research
  • Immunology Research
  • Neurology Research
  • Stem Cell Research
  • Other Research Applications
• Medical Applications
  • Noninvasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection
• Industrial Applications

Cell Counting Market by End User

• Market Overview
• Research Institutes
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
• Other End Users

Cell Counting Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tecan (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boule Diagnostics AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexcelom Bioscience LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tip Biosystems (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Logos Biosystems, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments